Johnson & Johnson Internal Documents Reveal Unsavory & Potentially Illegal Marketing of Antipsychotic drug Risperdal

The multi-billion dollar drug company, Johnson & Johnson (J&J), has come under fire for allegedly violating the rules in their marketing of Risperdal, an antipsychotic drug. Back in 1999, the Food and Drug Administration (FDA) told J&J that their marketing materials for geriatric patients overstated Risperdals benefits and minimized risks, according to Bloomberg.com. In 2000, an internal business plan strategized a way to increase Risperdals market share by marketing the benefits for elderly dementia, an unapproved use.

Drugged to Death: Soldiers returning from war are being given deadly cocktails of psychiatric drugs

Sgt. Eric Layne’s death was not pretty. A few months after starting a drug regimen combining the antidepressant Paxil, the mood stabilizer Klonopin and a controversial anti-psychotic drug manufactured by pharmaceutical giant AstraZeneca, Seroquel, the Iraq war veteran was “suffering from incontinence, severe depression [and] continuous headaches,” according to his widow, Janette Layne.

Doctor Who Criticizes Senators For “Attacking” Pharma in Washington Times Article Failed to Mention He’s Served Prison Time for Fraud

On March 4, 2010, The Washington Times posted a scathing op-ed by Dr. Gilbert Ross in which Ross slammed Senator Grassley, Senator Baucus and FDA Whistleblower David Graham. In a rambling tirade Ross accuses the trio of tinkering with the practice of medicine by unfairly criticizing pharmaceutical companies and defends GlaxoSmithKline (GSK) and their discredited drug

CCHR Applauds Study Exposing Financial Ties Between DSM Contributors and Pharma

The DSM—Psychiatry’s Billing Bible

Psychiatry’s Billing Bible: The Diagnostic and Statistical Manual of Mental Disorders (DSM) The American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM) is…